glutathione therapy for parkinson and Parkinson's Parkinson's Disease Treatment | IV

Sakuma A, Kai Y, Yamasaki Y, Tanaka T, Sakurai T

doi: 10.1016/j.cub.2014.03.034 246 SchmidlinC

Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1

Enhancing GSH, mainly through NAC, GSH precursors rich in cysteine (whey protein, whey protein isolate rich in cysteine) or pro-GSH compound administration, becomes a potential treatment option for inflammatory diseases by reducing oxidative stress and cytokine expression especially in diabetic patients that also are at risk of more severe COVID-19 disease (299)

De Los Santos JF, Small W

Old nagging injuries start feeling different